NATHAN GLASS: Open Payments
NPI 1043623663 · SMITHFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,647 in 95 payments from 22 companies in 2025. Trend: 2023 $2,479 · 2024 $2,663 · 2025 $1,647
Food & beverage: $1,647
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $305 |
| AstraZeneca Pharmaceuticals LP | 6 | $277 |
| PFIZER INC. | 14 | $206 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $151 |
| GlaxoSmithKline, LLC. | 11 | $148 |
| Azurity Pharmaceuticals, Inc. | 4 | $73 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Lilly USA, LLC | 4 | $59 |
| CSL Behring | 2 | $39 |
Products named: BREZTRI, JARDIANCE, TRELEGY ELLIPTA, NURTEC ODT, SPRAVATO, CAPLYTA, ELIQUIS, MOUNJARO.
Industry payments across PA — which companies pay providers there.
